1. Tyrosine kinase inhibitors in systemic sclerosis: The case for imatinib

   • Flavia V. Castelino
   • Swati Bhattacharyya
   • John Varga

   Clinical Trials Report 21 July 2009 Pages: 161 - 163

2. Juvenile dermatomyositis: The role of cytokine gene polymorphisms in conferring risk and protection

   • Emma Jane MacDermott
   • Thomas J. A. Lehman

   Clinical Trials Report 21 July 2009 Pages: 164 - 166

3. Clinical update on teriparatide

   • Elizabeth File
   • Chad Deal

   OriginalPaper 21 July 2009 Pages: 169 - 176

4. Bone health in systemic lupus erythematosus

   • Pantelis Panopalis
   • Jinoos Yazdany

   OriginalPaper 21 July 2009 Pages: 177 - 184

5. Advances in renal bone disease: Osteoporosis and chronic kidney disease

   • Sara Barnato
   • Stuart M. Sprague

   OriginalPaper 21 July 2009 Pages: 185 - 190

6. New insights: Elevated follicle-stimulating hormone and bone loss during the menopausal transition

   • Mone Zaidi
   • Harry C. Blair
   • Li Sun

   OriginalPaper 21 July 2009 Pages: 191 - 195

7. Denosumab for joints and bones

   • E. Michael Lewiecki

   OriginalPaper 21 July 2009 Pages: 196 - 201

8. The use of doppler ultrasound to evaluate lesions of localized scleroderma

   • Suzanne C. Li
   • Melissa S. Liebling

   OriginalPaper 21 July 2009 Pages: 205 - 211

9. The impact and implications of neuropsychiatric systemic lupus erythematosus in adolescents

   • Marisa Klein-Gitelman
   • Hermine I. Brunner

   OriginalPaper 21 July 2009 Pages: 212 - 217

10. Biomarkers for renal disease in childhood

    • Lena Das
    • Hermine I. Brunner

    OriginalPaper 21 July 2009 Pages: 218 - 225

11. Ocular complications of childhood rheumatic diseases: Nonuveitic inflammatory eye diseases

    • Andreas Reiff

    OriginalPaper 21 July 2009 Pages: 226 - 232